Your browser is no longer supported. Please, upgrade your browser.
Settings
BSPM Biostar Pharmaceuticals, Inc. daily Stock Chart
BSPM [NASD]
Biostar Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-2.79 Insider Own32.50% Shs Outstand2.65M Perf Week-4.86%
Market Cap4.66M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float2.20M Perf Month-18.14%
Income-5.70M PEG- EPS next Q- Inst Own4.30% Short Float14.32% Perf Quarter-39.31%
Sales2.40M P/S1.94 EPS this Y78.20% Inst Trans- Short Ratio5.49 Perf Half Y-53.81%
Book/sh14.43 P/B0.12 EPS next Y- ROA-13.00% Target Price7.00 Perf Year23.94%
Cash/sh0.08 P/C23.32 EPS next 5Y- ROE-15.10% 52W Range1.08 - 7.06 Perf YTD-39.93%
Dividend- P/FCF0.95 EPS past 5Y-17.80% ROI-15.90% 52W High-75.35% Beta1.93
Dividend %- Quick Ratio1.30 Sales past 5Y-51.80% Gross Margin38.40% 52W Low61.11% ATR0.19
Employees438 Current Ratio1.30 Sales Q/Q-83.30% Oper. Margin- RSI (14)28.80 Volatility10.44% 8.88%
OptionableNo Debt/Eq0.06 EPS Q/Q112.60% Profit Margin- Rel Volume0.41 Prev Close1.76
ShortableYes LT Debt/Eq0.00 EarningsMay 22 AMC Payout- Avg Volume57.34K Price1.74
Recom1.00 SMA20-15.96% SMA50-23.70% SMA200-43.60% Volume8,538 Change-1.14%
Nov-18-10Initiated Rodman & Renshaw Mkt Outperform $7
Apr-13-17 04:00PM  Biostar Pharmaceuticals, Inc. Announces Its Annual Results for The Year Ended December 31, 2016 PR Newswire
Feb-24-17 04:32PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule
Feb-09-17 04:33PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Nov-26-16 01:04PM  BIOSTAR PHARMACEUTICALS, INC. Financials
Nov-23-16 11:27AM  BioStar Pharmaceuticals, Inc. :BSPM-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016 +11.05%
Nov-21-16 04:30PM  Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended September 30, 2016 PR Newswire +10.68%
04:05PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
Oct-18-16 04:30PM  Biostar Pharmaceuticals Completes Previously Announced Registered Direct Financing PR Newswire +14.21%
Oct-12-16 12:53PM  Why Biostar Pharmaceuticals Inc.(BSPM), Telefonaktiebolaget LM Ericsson (ERIC), and Three Other Stocks Are Trading Lower Today at Insider Monkey -20.90%
09:19AM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events
09:18AM  Biostar Announces Execution of Agreement for $1.91 Million Registered Direct Offering of Shares of Common Stock and Warrants PR Newswire
Oct-11-16 03:30PM  Biostar Pharma Skyrockets on New Chinese Product Launch +61.81%
01:28PM  Why Biostar Pharmaceuticals Inc. (BSPM), Nova Lifestyle Inc. (NVFY) & Three Other Stocks Are Trading Higher on Tuesday at Insider Monkey
08:00AM  Biostar to Launch a New Product Aimed at Treating Effects of Rhinitis and Sinusitis PR Newswire
Sep-22-16 04:32PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events
08:00AM  Biostar Pharmaceuticals Signs a Letter of Intent to Acquire Xianyang Yongsheng Health Products Co., Ltd. PR Newswire
Aug-22-16 04:04PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
04:00PM  Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended June 30, 2016 PR Newswire
Jul-18-16 09:15AM  Stocks Coverage on the Healthcare Sector for Biostar Pharma, GlobeImmune, Neuralstem, and GW Pharma
Jun-28-16 11:41AM  BioStar Pharmaceuticals, Inc. :BSPM-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016
Jun-27-16 08:58AM  Coverage of Top Gainers on Biostar Pharma, Skullcandy, Finish Line and Electro Rent
Jun-24-16 01:30PM  Why Are These Five Stocks Trending Today? at Insider Monkey +30.58%
Jun-15-16 04:26PM  BioStar Pharmaceuticals, Inc.: Gathering momentum, can it sustain its performance? +6.40%
Jun-13-16 05:02PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jun-09-16 09:35AM  For These Small Cap Stocks it is All About Massive Growth -19.17%
May-23-16 04:05PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
04:00PM  Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended March 31, 2016 PR Newswire
Apr-14-16 04:06PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report +9.36%
04:00PM  Biostar Pharmaceuticals, Inc. Announces Its Annual Results for The Year Ended December 31, 2015 PR Newswire
Feb-24-16 09:01AM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -7.72%
09:00AM  Biostar Pharmaceuticals Regains Compliance with NASDAQ $1.00 Minimum Bid Price PR Newswire
Feb-16-16 09:00AM  Biostar Pharmaceuticals Airs Advertisements for its Analgesic (Pain Relief) Cream on China's CCTV PR Newswire +10.19%
Feb-05-16 04:46PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Amendments to -10.36%
09:00AM  Biostar Pharmaceuticals to Effect Reverse Stock Split PR Newswire
Dec-04-15 04:00PM  Biostar Pharmaceuticals Inc. Postpones its 2015 Annual Meeting of Shareholders PR Newswire
Nov-23-15 04:06PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
04:00PM  BiostarPharmaceuticals,Inc. Announces Its Quarterly Results for Three Months Ended September 30, 2015 PR Newswire
Nov-03-15 12:08PM  BioStar Pharmaceuticals, Inc. Value Analysis (NASDAQ:BSPM) : November 3, 2015 Capital Cube
Aug-28-15 04:33PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule
Aug-19-15 04:30PM  Biostar Pharmaceuticals,Inc. Announces Its Quarterly and Half Year Results for 2015 PR Newswire
04:05PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
May-15-15 04:43PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
04:30PM  Biostar Pharmaceuticals,Inc. Announces Its Quarterly Results for Three Months Ended March 31, 2015 PR Newswire
May-04-15 06:33AM  Biostar Pharmaceuticals, Inc. Announces Its Full Year and Fourth Quarter 2014 Financial Results at noodls
Apr-17-15 06:03PM  Nasdaq stocks posting largest volume increases
Apr-15-15 05:04PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition
04:30PM  Biostar Pharmaceuticals, Inc. Announces Its Full Year and Fourth Quarter 2014 Financial Results PR Newswire
04:13PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
Jan-08-15 08:00AM  Biostar Pharmaceuticals, Inc. Announces Signing of Joint Research and Development Agreement with Northwest University for Further Development of Danshensu Yibingzhi (IDHP), a Class One Drug for Treatment of Cardiovascular Diseases PR Newswire
Dec-05-14 05:01PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Nov-15-14 02:57AM  Biostar Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results at noodls
Nov-14-14 09:01AM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
09:00AM  Biostar Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results PR Newswire
Oct-23-14 04:31PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements
Sep-18-14 08:00AM  Biostar Pharmaceuticals, Inc. Files a PRC Patent Application for Oleanolic Acid Injection, its New Drug Product for Hepatitis B and Liver Cancer PR Newswire
Aug-27-14 08:00AM  Biostar Pharmaceuticals Inc. Engaged Chief Scientist Professor Xiaohui Zheng To Preside Over The Company's Product Development Projects PR Newswire
Aug-18-14 02:11PM  Sinopharm, Biostar, Lilly Rise on Medical Modernization in China at TheStreet
Aug-14-14 08:01AM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
08:00AM  Biostar Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results PR Newswire
Aug-04-14 08:00AM  Biostar Pharmaceuticals Inc. Established a Sales and Marketing Task Team to Promote Sales to Hospital Facilities in Ten PRC Provinces PR Newswire
May-15-14 04:14PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
04:01PM  Biostar Pharmaceuticals, Inc. Announces First Quarter 2014 Financial Results PR Newswire
Mar-31-14 04:32PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report EDGAR Online
04:30PM  Biostar Pharmaceuticals, Inc. Announces Full Year 2013 Financial Results PR Newswire
Mar-10-14 08:16AM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial EDGAR Online
08:00AM  Biostar Announces Execution of Agreement for $4.1 Million Registered Direct Offering of Shares of Common Stock and Warrants PR Newswire
Mar-09-14 03:31AM  China Biotech In Review: iKang Healthcare Planning $150 Million IPO In U.S. at Seeking Alpha
Mar-06-14 08:10AM  Biostar Pharmaceuticals to develop liver cancer drug with Chinese university theflyonthewall.com
08:00AM  Biostar Pharmaceuticals, Inc. Partners with Shaanxi University of Chinese Medicine to Co-develop Liver Cancer Drug PR Newswire
Feb-20-14 04:31PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
08:00AM  Biostar Pharmaceuticals, Inc. Expects 2013 Yearly Revenue Growth above 20% with Break Even Operating Results as Compared With Last Year's USD$21.8 Million Loss from Operations PR Newswire
Feb-14-14 08:00AM  Biostar Held Its Strategic Development Seminar; Identified Development Planning for 2014 - 2016 PR Newswire
Jan-15-14 08:00AM  Biostar Pharmaceuticals, Inc. Announces the Designation of its PRC Operating Subsidiary as the Shaanxi Province Liver Disease Health Education Base PR Newswire
Jan-10-14 08:00AM  Biostar Pharmaceuticals, Inc. Announces Opening of a Sales Office in Gansu Province, PRC PR Newswire
Nov-27-13 04:31PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Nov-18-13 06:04PM  Nasdaq stocks posting largest volume increases AP
Nov-15-13 11:24AM  Biostar Pharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha
Nov-14-13 04:12PM  InPlay: Biostar Pharma reports Q3 EPS of $0.03, no estimates, vs. ($0.63) year ago; net sales increased 50.1% y/y to $15.01 mln Briefing.com
04:00PM  Biostar Pharmaceuticals, Inc. Announces Third Quarter 2013 Financial Results PR Newswire
08:00AM  Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2013 Third Quarter Earnings Conference Call on Friday, November 15, 2013 at 9:30 a.m. ET PR Newswire
06:02AM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Nov-13-13 08:00AM  Biostar Pharmaceuticals, Inc. Regains Compliance With NASDAQ $1.00 Minimum Bid Price Rule PR Newswire
Nov-01-13 04:01PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule EDGAR Online
Aug-20-13 12:26PM  Biostar Pharmaceuticals' CEO Discusses Q2 2013 Results - Earnings Call Transcript at Seeking Alpha
Aug-19-13 04:32PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
04:30PM  Biostar Pharmaceuticals, Inc. Announces Second Quarter 2013 Financial Results PR Newswire
07:30AM  Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2013 Second Quarter Earnings Conference Call on Tuesday, August 20, 2013 at 9:30 a.m. ET PR Newswire
May-16-13 02:29PM  Biostar Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha
07:00AM  Biostar Pharmaceuticals, Inc. Announces First Quarter 2013 Financial Results PR Newswire
May-15-13 09:29AM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
07:07AM  Q1 2013 Biostar Pharmaceuticals Inc Earnings Release - After Market Close CCBN
May-14-13 07:00AM  Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2013 First Quarter Earnings Conference Call on Thursday, May 16, 2013 at 9:00 a.m. ET PR Newswire
May-06-13 09:31AM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule EDGAR Online
Apr-16-13 06:33AM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
Apr-15-13 03:44PM  Biostar Pharmaceuticals' CEO Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha
09:00AM  Biostar Pharmaceuticals, Inc. Reports 2012 Results PR Newswire
07:07AM  Q4 2012 Biostar Pharmaceuticals Inc Earnings Release - Before Market Open CCBN
02:18AM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report EDGAR Online
Apr-09-13 07:30AM  Biostar Pharmaceuticals, Inc. to Host Fiscal 2012 Year End Earnings Conference Call on Monday, April 15, 2013 at 9:30 a.m. ET PR Newswire
Mar-15-13 04:03PM  BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial Statements and Ex EDGAR Online
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. Its product line also includes 12 other OTC products and 17 prescription-based pharmaceuticals. The company's OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. Its prescription pharmaceutical products include Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Hernia belt; Tangning capsule; Yizi capsule; Shengjing Capsule; Aoxing Ointment; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. The company also operates a Website that serves as Internet-based China Hepatitis Internet hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of sales people in approximately 28 provinces. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.